ViraTherapeutics
ViraTherapeutics develops and commercializes viral-based immuno-oncology therapies for the treatment of cancer.
Business Model:
Revenue: $2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed ViraTherapeutics Information
ViraTherapeutics was acquired by
Boehringer Ingelheim.
The acquisition happend on 2018-09-13.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Bundesstrasse 27
City: Rum
State: tyrol
Zip: 6063
Country: AT
Financial Info
Stage:
series a
Raised Last:
$4M
Raised Total:$4M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
ViraTherapeutics develops and commercializes viral-based immuno-oncology therapies for the treatment of cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2015 | Series A | 3 | $4M |
aws Fondsmanagement GmbH Boehringer Ingelheim Venture Fund EMBL Ventures aws Fondsmanagement GmbH Boehringer Ingelheim Venture Fund EMBL Ventures |
6/2015 | Series A | $4M |
Boehringer Ingelheim Venture Fund EMBL Ventures Austria Wirtschaftsservice GmbH |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
